Pacific Biosciences Collaboration with Labcorps Focused on SARS-CoV-2 and COVID-19

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes -- and a CNF start up company from the 90s -- today announced initial findings from the company’s research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19.